Rani Therapeutics (RANI)
(Delayed Data from NSDQ)
$3.20 USD
+0.38 (13.48%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $3.20 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 10.34% |
ABR | 1.00 |
Earnings ESP
|
14.62% |
---|---|
Current Year | -0.98 |
Next Year | -0.72 |
EPS (TTM) | -1.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.22 | -0.98 | -0.72 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | NA | NA | -1.06 | NA |
High Estimate | -0.12 | -0.12 | -0.78 | -0.48 |
Low Estimate | -0.28 | -0.28 | -1.10 | -0.89 |
Year ago EPS | -0.36 | -0.27 | -1.33 | -0.98 |
Year over Year Growth Est. | 38.89% | 18.52% | 26.32% | 27.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.22 | -0.98 | -0.72 |
7 Days Ago | -0.22 | -0.22 | -0.98 | -0.72 |
30 Days Ago | -0.29 | -0.29 | -1.05 | -0.88 |
60 Days Ago | -0.29 | -0.29 | -1.05 | -0.88 |
90 Days Ago | -0.29 | -0.29 | -1.05 | -0.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.19 | -0.98 | -0.63 |
Zacks Consensus Estimate | -0.22 | -0.22 | -0.98 | -0.72 |
Earnings ESP | 14.62% | 13.64% | 0.00% | 12.09% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.29 | -0.27 | -0.36 | NA |
Estimate | -0.29 | -0.23 | -0.31 | -0.47 | NA |
Difference | 0.03 | -0.06 | 0.04 | 0.11 | 0.03 |
Surprise | 10.34% | -26.09% | 12.90% | 23.40% | 5.14% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more